GERM ETFMG Treatments, Testing and Advancements ETF
ETF Price & Overview

$17.37-0.04 (-0.21%)10:28 AM 10/03/23

NYSEARCA | $USD | Post-Market: $17.37 -0.00 (-0.00%) 8:00 PM

Quant Ranking

Analysis

News

Latest Headlines

ETFMG Treatments, Testing and Advancements ETF declares quarterly distribution of $0.0400

ETFMG Treatments, Testing and Advancements ETF declares quarterly distribution of $0.0600

Biotech ETFs rally in Q4 fueled by 70%+ surge in Moderna

GERM ETF: A New Player In The Infectious Disease Segment

Check out the ETF that’s dropped 5% off the Moderna & BioNTech selloff

Broad healthcare leads all industries in ETF investor flow over the past 3-months

ETF closing bell featuring: BDRY, URA & URNM

NASDAQ Biotech Index crosses 5K mark as vaccine makers and gene-editors surge

U.S. is bracing for post-Christmas COVID-19 surge

Broad Exposure To COVID-19: ETFMG Treatments Testing And Advancements ETF

ETF Grades

	Now	3M ago	6M ago
Momentum			-Rating: Not Covered
Expenses			-Rating: Not Covered
Dividends			-Rating: Not Covered
Risk			-Rating: Not Covered
Liquidity			-Rating: Not Covered

Fund Profile

Fund Details

Returns

	1Y	3Y	5Y	10Y

Holdings Breakdown

Top 10 Holdings

Dividend Growth History

More On Dividend Growth »

Momentum

Peers

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.